These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1964449)
1. Effect of human urinary colony-stimulating factor on experimental Legionella pneumophila infection in guinea pigs. Owan I; Saito A J Antimicrob Chemother; 1990 Dec; 26(6):831-40. PubMed ID: 1964449 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Edelstein PH; Edelstein MA Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571 [TBL] [Abstract][Full Text] [Related]
3. The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes. Fitzgeorge RB; Featherstone AS; Baskerville A J Antimicrob Chemother; 1988 Sep; 22 Suppl C():53-7. PubMed ID: 3182462 [TBL] [Abstract][Full Text] [Related]
4. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. Nash TW; Libby DM; Horwitz MA J Clin Invest; 1984 Sep; 74(3):771-82. PubMed ID: 6470140 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101 [TBL] [Abstract][Full Text] [Related]
6. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. Edelstein PH; Shinzato T; Edelstein MA J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556 [TBL] [Abstract][Full Text] [Related]
7. Effects of tetracyclines on experimental Legionella pneumophila infection in guinea-pigs. Yoshida S; Mizuguchi Y; Ohta H; Ogawa M J Antimicrob Chemother; 1985 Aug; 16(2):199-204. PubMed ID: 4066557 [TBL] [Abstract][Full Text] [Related]
8. Temperature effects on Legionella pneumophila killing by and multiplication in phagocytes of guinea pigs. Miyamoto H; Ogawa M; Maruta K; Nikaido Y; Yamamoto C; Taniguchi H; Yoshida S Microbiol Immunol; 1995; 39(9):647-54. PubMed ID: 8577277 [TBL] [Abstract][Full Text] [Related]
9. The effect of antibiotics on the growth of Legionella pneumophila in guinea-pig alveolar phagocytes infected in vivo by an aerosol. Fitzgeorge RB J Infect; 1985 May; 10(3):189-93. PubMed ID: 3161953 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Edelstein PH; Shinzato T; Doyle E; Edelstein MA Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675 [TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. Edelstein PH; Edelstein MA; Lehr KH; Ren J J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752 [TBL] [Abstract][Full Text] [Related]
12. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia. Edelstein PH; Weiss WJ; Edelstein MA Antimicrob Agents Chemother; 2003 Feb; 47(2):533-40. PubMed ID: 12543655 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of severe respiratory infection. Legionella pneumonia]. Saito A Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):281-5. PubMed ID: 2615084 [TBL] [Abstract][Full Text] [Related]
14. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease. Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201 [TBL] [Abstract][Full Text] [Related]
15. Intracellular multiplication of Legionella pneumophila in HL-60 cells differentiated by 1,25-dihydroxyvitamin D3 and the effect of interferon gamma. Watanabe M; Shimamoto Y; Yoshida S; Suga K; Mizuguchi Y; Kohashi O; Yamaguchi M J Leukoc Biol; 1993 Jul; 54(1):40-6. PubMed ID: 8336078 [TBL] [Abstract][Full Text] [Related]
16. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. Stamler DA; Edelstein MA; Edelstein PH Antimicrob Agents Chemother; 1994 Feb; 38(2):217-22. PubMed ID: 8192446 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp. Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952 [TBL] [Abstract][Full Text] [Related]
19. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Edelstein PH; Edelstein MA; Holzknecht B Antimicrob Agents Chemother; 1992 Nov; 36(11):2387-91. PubMed ID: 1489182 [TBL] [Abstract][Full Text] [Related]
20. IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. Nash TW; Libby DM; Horwitz MA J Immunol; 1988 Jun; 140(11):3978-81. PubMed ID: 3131422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]